I. INTRODUCTION
Amorphous or disordered aggregation is a process that occurs often in nature. For example, it is associated with several age-related diseases such as cataract ͓1͔ and can result in the formation of protein haze in white wines ͓2͔. It is also the bane of protein expression and purification for many biochemists, leading to protein precipitation and subsequent loss of protein, data, and time. Despite amorphous protein aggregation being such a significant problem, it has received little research attention and is often overshadowed by studies of protein aggregation leading to highly structured linear amyloid fibrils associated with neurodegenerative disorders, such as Alzheimer's and Parkinson's diseases ͓3͔.
Crystallin proteins in the eye lens are thought to be destabilized due to a lifetime of oxidative and radiative stress and unfold into aggregation-prone species that are precursors to cataract formation ͓4͔. Cataract affects many aged people and is a particular problem in developing countries where, as a result, an estimated 24 million people are blind ͓5͔. Currently, the principal treatments for cataract are removal of the opacified lens and replacement with an artificial lens ͓6͔.
Protein wine haze presents a significant problem to the wine industry. Currently, bentonite clay is used to adsorb the troublesome proteins from white wine which is then filtered back off the clay ͓2͔. While this is effective in removing the proteins, it adversely affects the quality and quantity of the treated wine and also presents waste disposal issues ͓7͔. It is estimated that the cost of bentonite fining to the wine industry worldwide is in the order of $300-500 million per annum ͓7͔. Studies that describe the mechanism of protein wine haze formation are highly desirable as they will lead to improved technologies, maintaining wine quality and decreasing the costs of production ͓2͔.
In order to find solutions to these problems, there is a need to understand and model the processes and kinetics of the amorphous aggregation phenomena. There are many mathematical models in the literature for linear aggregation mechanisms, as reviewed by Morris et al. ͓8͔ . A unique approach was undertaken by Flyvbjerg et al. ͓9, 10͔ , who studied the self-assembly of microtubules, a linear aggregation mechanism, and derived a mathematical model to describe the phenomenon. However, there are few, if any, mathematical models of amorphous aggregation. In this paper, we propose a model for amorphous aggregation processes and demand that certain constraints, which are found by performing a data analysis similar to that by Flyvbjerg et al. ͓9͔, are imposed. The data shown here are turbidity measurements for the aggregation of heat-stressed thaumatin, a protein structurally very similar to thaumatinlike ͑TL͒ proteins, which play a major role in protein wine haze formation ͓11͔. We fit these data using our amorphous aggregation model. The analysis is also performed on ␣-lactalbumin ͑␣-LA͒, a well-characterized protein that amorphously aggregates upon reduction of its disulfide bonds ͓12͔, and is often used as a test protein to monitor the activity of molecular chaperone proteins ͓12,13͔. In addition, we monitor the aggregation of, and apply our model to, a Vitis vinifera TL grape protein. These three diverse proteins give very similar results, indicating the broad application of the model and its applicability to other systems which behave in a similar manner, such as the formation of colloids and nanoclusters ͓14,15͔ and vapor condensation ͓16͔. Figure 1͑a͒ shows a set of experimental turbidity ͑A͒ data for a range of initial concentrations of thaumatin ͑between 2.0 and 4.0 mg/ml͒ upon heating at 60°C. Overlaid are fits by the model to the experimental data. Data and fits for the TL protein and ␣-LA are shown in Figs. 7 and 8 of Appendix A, respectively.
II. EMPIRICAL DATA ANALYSIS
The data points follow similar sigmoidal curves, with initial lag times, followed by a steep rise and subsequent plateau. The curves differ only by the magnitude of the increase in turbidity due to different initial protein concentrations; the lag times are very similar. Therefore, the issue of whether they differ only through the overall time and turbidity axes is addressed following the reasoning of Flyvbjerg et al. ͓9͔. If that is the case, then the curves are said to "scale" over one another, following a scaling law.
We do this by finding the asymptotic turbidity, A ϱ , and the time taken to reach half this value, the half time, t 0 , for each data set. Upon scaling the turbidity and time axes with their respective characteristic parameters, the data collapse to a single curve ͓Fig. 1͑b͒ and Figs. 7 and 8 in Appendix A͔. The interpretation of this is that, independent of the initial monomer concentration, a single mechanism of protein aggregation is present over the concentration range considered. This allows use of a single curve for the modeling which may be unscaled to reproduce the original data.
Furthermore, we seek to obtain a relationship between the characteristic parameters A ϱ and t 0 . Following the analysis in Ref. ͓9͔, a double-logarithmic plot of t 0 versus A ϱ yields a straight line ͑Fig. 2 and Figs. 9 and 10 in Appendix B͒, which indicates a power law relationship of the form
where ͑−m͒ is the slope of the double-logarithmic plot and is some constant of proportionality. For thaumatin, the mean result of the three replicates is m = 0.077Ϯ 0.002, where the quoted error is the SE of the mean. For the grape TL protein and ␣-LA, we obtain m = 0.039Ϯ 0.011 and 2.04Ϯ 0.39, respectively ͑see Figs. 9 and 10 in Appendix B͒.
Consequently, without the use of any theory, we have empirically obtained two independent constraints on our model from the experimental observations-the scaling and power laws.
III. MODEL

A. Linear versus amorphous aggregation
In simplistic terms, the aggregation of monomeric entities ͑e.g., proteins͒ to form linear chains such as amyloid fibrils and the self-assembly of microtubules, as modeled by ͓9͔, are linear mechanisms; the aggregating "monomers" can 1.0 2.0 mg/ml 2.5 mg/ml 3.0 mg/ml 3.5 mg/ml 4.0 mg/ml γ = 0.67 iso
FIG. 1. ͑a͒ Typical experimental data for thaumatin at various initial concentrations, incubated at 60°C in a model wine solution ͑see Appendix A for details͒. The dashed line overlaid shows the fits to the data by the model derived in this paper with a spherical exponent, ␥ =2/ 3 Ϸ 0.67. ͑b͒ The experimental data from ͑a͒, with the time and turbidity axes scaled by the half time, t 0 , and asymptotic turbidity, A ϱ , respectively, for each series. The data sets "collapse" to a single curve, thus obeying a scaling law. The dashed curve represents the same unique fit by the model to this scaled data ͑with ␥ = 0.67͒ as the family of curves in ͑a͒.
only add on to either end of the aggregate in a onedimensional ordered manner. As the aggregate increases in length, the rate of aggregation should therefore not increase because there is no greater surface area available to the monomers.
Conversely, amorphous aggregation can be thought of as a disordered three-dimensional process, where monomers can add from any direction. Consequently, we must account for the fact that as the aggregates increase in size, the surface area available to the monomers increases and hence there should be a corresponding increase in the rate of aggregation. This will be the third constraint on the model, in addition to the scaling and power laws. Figure 3 compares the linear and amorphous aggregation mechanisms schematically.
B. General framework
A similar formalism to that introduced in Refs. ͓9,10͔ is followed here. We let M͑t͒ denote the total mass of monomers contained in the aggregates and c͑t͒ be the monomer concentration ͑both in units of arbitrary concentration, such as mass density͒. Clearly, conservation of mass gives us the relation ͓9,10͔
M͑t͒
where c͑0͒ϵc 0 is the initial protein monomer concentration ͑at time t =0͒. In addition, we see from Eq. ͑2͒ that M ϱ , the asymptotic mass as time approaches infinity, is equal to the initial monomer concentration, c 0 , because c͑t͒ goes to zero ͓9,10͔. Furthermore, it is assumed that turbidity, A͑t͒, is proportional to the aggregate volume and hence mass in aggregates, M͑t͒. 1 Thus, we see that A ϱ ϰ M ϱ = c 0 . Note that the asymptotic turbidities, A ϱ , thus scale linearly with the initial monomer concentration, c 0 . Inspection of Fig. 1 indicates that experimentally, the linear correlation between A ϱ and c 0 is only approximate and we attribute this primarily to experimental errors in preparing the monomer concentrations. In any case, the exact values for concentration are not important and are not required in the analysis at any point. It is only necessary to obtain data sets for different concentrations for a given protein.
The data shown are all relative to the asymptotic turbidity at the reference concentration, c 0 ref = 4.0 mg/ ml. The scaling law observed earlier gives motivation to introduce dimensionless "scaling variables." Therefore, we define tЈ, AЈ, MЈ, and cЈ such that 
C. Amorphous aggregation model
The mass in the aggregates, M͑t͒, will increase with time as monomers continue to add onto the cluster. The rate of this increase will depend on the concentration, c, of available monomers. One therefore expects that on one hand, this rate will obey a power law of the form
for some as yet undetermined exponent, r Ն 0. We keep this power general, allowing it to deviate from the classical value of 1 for simple first-order kinetics. First of all, our system is heterogeneous-the "reacting" monomer entities need to first be activated by being partially unfolded. The denaturation process, e.g., achieved by heating, results in a statistical distribution of monomer states, some of which are completely unfolded, others which remain in their native form, and many others in between, i.e., which are partially unfolded. Thus, only a certain proportion s is able to aggregate at any given time. Moreover, in the presence of density dependent mechanisms, such as collisions between monomers which may lead to activation or refolding, it is to be expected that this proportion also depends on their density, as modeled, for example, by another power law, s ϰ c ␦ , leading to r =1+␦. Hence we allow for deviation from r = 1 in Eq. ͑4͒.
On the other hand, we must also take into account the requirement that the rate of aggregation increases as the aggregates grow in size. Assuming for simplicity that their average size grows in proportion to some other power, ␥, of their mass, M, we require a factor of the form
where the exponent ␥ Ն 0 is also a priori unknown. Combining Eqs. ͑4͒ and ͑5͒, we obtain a rate equation of the form
where the constant f is to be determined experimentally. This relationship holds when treating the turbidity measurements as being due to Rayleigh scattering, where the size of the aggregates is much less than the wavelength used to analyze them ͓17͔. Transmission electron microscope images ͑not shown͒ verified this, where only the largest protein aggregates just exceed the wavelength of the turbidity measurements, 340 nm. Nevertheless, the approximation is valid for the majority of the aggregation time series and is therefore assumed to hold for the entire process.
FIG. 3.
Left: linear aggregation mechanisms are ordered onedimensional processes and monomers can only add onto the ends of the aggregate chain. Right: amorphous aggregation is a disordered three-dimensional process, where monomers can add on to aggregates from any direction.
In order to account for the observed scaling, we first introduce the dimensionless variables of Eq. ͑3͒. In terms of these variables, Eq. ͑6͒ reads
is a scaled dimensionless rate constant to determine the overall rate of the process.
The observed scaling requires the rate equation in terms of the scaling variables ͓Eq. ͑7͔͒ to be independent of the initial concentration, c 0 , as in Refs. ͓9,10͔. Therefore, an additional constraint is r = m +1−␥. With the power law in Eq. ͑1͒ and scaling, the amorphous aggregation model then predicts an exponent in Eq. ͑4͒ different from r = 1 whenever m ␥.
Since Eq. ͑2͒ tells us that cЈ =1− MЈ, the final equation for the amorphous aggregation model, including an appropriate initial condition, then reads
While the exponent m is obtained from the empirical data analysis discussed above, the exponent ␥, introduced in Eq. ͑5͒, and the rate constant fЈ may be used to model different systems.
D. General solution
To allow for a potential lag time before the onset of aggregation, we introduce a characteristic parameter t lag Ј associated with the sigmoidal curves by replacing tЈ → tЈ − t lag Ј .
The general solution to Eq. ͑8͒ is then found, by integration, to be implicitly given by the equation
where 2 F 1 is a hypergeometric function defined by the expansion
are the Pochhammer symbols and ⌫ is the gamma function ͓18͔. For z = MЈ in our case it is straightforward to verify that the series converges because 0 Յ MЈ Յ 1.
Depending on the model assumptions, i.e., whether a lag phase is to be included and/or whether the exponent ␥ is fixed by a model assumption on the geometry of the amorphous aggregation process or used as a free parameter, we have various options to fit the implicit solution of Eq. ͑9͒ for MЈ͑tЈ͒ to the scaled experimental data. We can either use the effective rate constant fЈ as the only parameter ͑with all others fixed͒ or include the aggregation geometry exponent ␥ and/or an additional lag time via t lag Ј to perform the fits, thus including up to at most three free parameters.
E. Aggregation geometry
As discussed above, the exponent ␥ in the aggregation rate equation is introduced to account for an increase in the area available to the monomers to add on to the aggregate. This area can be the total surface area of the aggregates in some cases but it might be only some part of that in others. The exponent ␥ describes how the effective area relevant to the aggregation process ͑i.e., presented to the monomers͒ increases with the volume and hence the mass of the aggregates.
In linear aggregation such as amyloid fibril formation, for example, this effective area is independent of the volume which corresponds to ␥ = 0 for one-dimensional aggregation.
Another interesting special case is that of an isotropic aggregation process in three dimensions as also sketched in Fig. 3 . In this case, the effective area, A eff , and hence rate of aggregation increase with the square of the aggregate's radius R, while the volume V increases as R 3 . Therefore, at constant density,
We call ␥ =2/ 3 the exponent for spherical or isotropic aggregation. Larger values, ␥ Ͼ 2 / 3, are possible when the area increases faster than that relative to the volume. This could be due to a roughening of the surface, for example.
When a deformation develops, on the other hand, there are preferential directions of aggregation singling out a certain fraction of the total surface, with the result that the relevant effective area, A eff , will grow slower than the aggregate's total surface. Simple examples are prolate deformations which in the extreme case lead to linear aggregation again or oblate deformations. The latter might be modeled by a flat cylinder of increasing radius R but constant height. Then, only the outer wall of the cylinder attracts further monomers and the effective area increases only linearly with the radius, A eff ϰ R, while the volume increases as R 2 . This gives
so that we call ␥ =1/ 2 the exponent for cylindrical aggregation, which of course is a two-dimensional process.
IV. THAUMATIN RESULTS
A. Isotropic model
We first assume isotropic aggregation and fix ␥ =2/ 3 Ϸ 0.67 as the spherical exponent in our fits. The dashed lines in Figs. 1͑a͒ and 1͑b͒ show the nonlinear regression fit to one of the replicates for thaumatin, fixing ␥ =2/ 3 and using fЈ and t lag Ј as fitting parameters.
2 This is the same fit as the dashed line for replicate A1 in Fig. 4 . Almost identical results are obtained for replicates B1 and C1 ͑dashed lines͒, also shown in Fig. 4 .
By inspection of the fits, the spherical exponent, ␥ =2/ 3, for isotropic ͑iso͒ aggregation is very well suited to describe the data for the earlier times, t Ͻ t 0 . At later times, t Ͼ t 0 , the quality of the fits deteriorates, however. The assumption of isotropic aggregation appears to break down in the final phase of the process typically after the half time, t 0 .
B. Global fits
Since these observed deviations from the isotropic aggregation model could either be due to anisotropies in the aggregation or roughening of the surface, as explained above, we adopt an alternative model in which the exponent ␥ is varied to optimize the fits over a range of times around t 0 , so chosen as to include the essential part of the aggregation process ͑excluding very early and very late times͒. To this end, we scan the range of exponents 0 Յ ␥ Ͻ 1 in increments of 0.01.
3 This is done using a simple MATHEMATICA routine to obtain for each value of ␥ a nonlinear regression fit using fЈ and t lag Ј as the two free parameters. The estimate of the variance is plotted for each value against ␥ in Fig. 5 . 4 The data range for the fits around t 0 is chosen as 2 / 3 Յ tЈ Յ 4 / 3. 5 This window includes the majority of the crucial central data and is mainly chosen to exclude the extremities. The fits are otherwise stable under variations of this range within reasonable limits. For each of the three replicates we separately obtain a value of ␥, termed ␥ fit , minimizing the estimated variance, 2 , as shown in Fig. 5 . These values for the best fit over the transition range lead to a global average over the three sets of ␥ fit = 0.47Ϯ 0.02 for thaumatin. Figures 11 and 12 in Appendix B, respectively, show similar plots for the TL protein and ␣-LA, resulting in ␥ fit = 0.37Ϯ 0.09 and ␥ fit = 0.56Ϯ 0.18, respectively.
Replicates A1, B1, and C1 in Fig. 4 show the fits ͑solid lines͒ resulting for each of the three sets of scaled thaumatin experimental data ͑symbols͒ obtained with their respective optimized geometry exponents, ␥ fit . An excellent agreement between fit and data is observed, in particular at later times, t Ͼ t 0 , where the isotropic model ͑iso-dashed lines͒ starts to fail.
V. DISCUSSION
Our interpretation of these results is that they provide compelling evidence that the aggregation process for thaumatin is very well described by an isotropic threedimensional process ͑corresponding to the spherical exponent, ␥ =2/ 3͒ in the early phases leading up to the half time, t 0 . After that, better fits are obtained for a value of ␥ fit near 1/2 which implies that the aggregates start to develop more of an oblate deformation eventually leading to an aggregation corresponding to the cylindrical exponent, ␥ =1/ 2. The two-dimensional model matches the data particularly well during the late stages of the aggregation process and, in this phase, it provides a very good description even considerably beyond the range used for the fits.
Replicates A2, B2, and C2 in Fig. 4 show the original thaumatin experimental data with the same fits using the ␥ fit values, but after the original scaling from the left column, corresponding to Eq. ͑3͒, is undone. Table I gives a summary of the values obtained for the various parameters of the three proteins. In order to compare different systems such as different proteins, it is furthermore useful to define a proper rate constant, f ϵ fЈ / , upon division by the characteristic time from the power law of Eq. The MATHEMATICA ͑Wolfram Research, Champaign, IL͒ function NonLinearRegress is used for all of the fitting procedures. In this procedure, the estimates of the model ͑fitting͒ parameters are chosen to minimize the 2 merit function, a function which measures the difference between data and the fitting model for a particular choice of the parameters given by the sum of squared residuals ͓19͔. The MATHEMATICA statistical output EstimatedVariance is equivalent to the squared sum of fit residuals ͑difference between data and fit estimate at any point͒ divided by the number of degrees of freedom ͓19͔.
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The fitting window midpoint for ␥ =2/ 3 was chosen to be the inflection point which is reached slightly before the half time, t 0 . The difference is insignificant, however. ͑1͒. This definition is independent of the reference concentration, c 0 ref , used in the turbidity measurements, and the results for f are also quoted in Table I . Details of corresponding analyses for the TL protein and ␣-LA are included in Appendixes A and B. We found that the values of r for thaumatin ͑and the TL protein͒ were less than 1, the value expected from first-order kinetics. We rationalize this on the basis that heating is used to activate the monomers for aggregation. As a result, a statistical distribution of monomers is present, some of which are still in their native ͑folded͒ form, others which are partially unfolded, and others which are completely unfolded. Therefore, a certain proportion of the total monomers present in the system is unavailable for aggregation ͑e.g., those in the native form͒. In physical terms, when this proportion is smaller at larger densities, due to an increased number of collisions for example, this can give rise to an r value decreased from 1. Conversely, the r value for ␣-LA was found to be greater than 1. In this case, however, a reducing agent was used to induce aggregation by breaking the four disulfide bonds of ␣-LA to cause the protein to partially unfold. This chemical method results in practically all of the monomers being partially unfolded ͓12͔ and therefore activated for aggregation, and it can therefore not explain the observed r value larger than 1. Rather, the resulting value of r around 2.5 may indicate that a few nucleation steps, where more than one monomer is involved in forming the nuclei, might need to be included in the pathway to aggregation for ␣-LA. This is beyond the scope of the present model and will be left as a future extension.
Further verification of the validity of the model requires a thorough analysis of the early and late-time data. Figures  6͑a͒ and 6͑b͒ show the thaumatin experimental aggregation data from Fig. 1͑a͒ for early and late times, respectively, emphasized on respective double-logarithmic and semilogarithmic axes ͑the same trends are seen for the TL protein and ␣-LA data, not shown here͒. For the early-time case, the monomer concentration changes very little ͑c ϳ c 0 ͒, so the entire system is described by Eq. ͑5͒ only. Integrating this equation gives
for early times. Therefore, our model predicts that doublelogarithmic plotting of early-time aggregation data should result in straight lines ͑of slope 1 1−␥ ͒. This behavior is observed very clearly as shown for thaumatin in Fig. 6͑a͒ where we included the isotropic aggregation model fits with ␥ =2/ 3 for the limiting values of the initial monomer concentrations from Fig. 1 to indicate the band of lines expected for initial concentrations between 2.0 and 4.0 mg/ml. After about 2 min the data align with this band and we conclude that the three-dimensional isoptropic model with M ϰ t 3 captures the early-time behavior of the aggregation process very well.
For the case of late times, one might intuitively expect a simple exponential decay of the monomer concentration. However, this requires r =1+m − ␥ = 1. Otherwise the aggregation process would be fully completed in maybe large but strictly speaking finite time as can be seen from Eq. ͑9͒ which results in a finite tЈ = t max Ј for MЈ = 1 when 1 + m − ␥ = r differs from 1. As this would appear to be rather unphysical we must assume that r = 1 at least asymptotically at late times. Then, from Eq. ͑9͒,
where the constant of proportionality depends on ␥ = m. The late-time data for M ϱ − M of thaumatin are compared to such model solutions with r = 1 and exponential decay in Fig. 6͑b͒ . The dashed line is obtained when using the value of the exponent m from the power law ͓Eq. ͑1͔͒, i.e., with ␥ = m = 0.08. The solid line is the result of an independent fit of this parameter to the late-time data which incidentally leads to a value ␥ = m = 0.45 coinciding with the result of the Fig. 1͑a͒ , showing early times. The data follow a straight line behavior, and this property can be readily captured by the model. ͑b͒ Thaumatin experimental aggregation ͑turbidity͒ data from Fig. 1͑a͒ for late times, presented as monomer concentration ͑c ϰ A ϱ − A͒. The plots exhibit asymptotic decay, and the inset shows the A ϱ − A axis logarithmically, giving approximate straight line behavior. These late-time properties can be accounted for when setting r = 1 which implies ␥ = m. The dashed line shows the original fit for c 0 = 4.0 mg/ ml with ␥ = m = 0.08 as obtained from the power law in Eq. ͑1͒. The solid line shows the result of an independent fit of this parameter to the late-time data resulting in m = ␥ = 0.45 which is precisely the same value as obtained from the global fit for the geometry exponent ␥ to these data ͓replicate A in Fig. 4 ͑see panel A2͔͒.
global fit for the geometry exponent ␥ fit to these data, replicate A ͓see Fig. 4 ͑A2͔͒, as described in Sec. IV B. Identical values are obtained for replicates B and C with very small errors. They are all consistent with the thaumatin average of the global fit parameter ␥ fit = 0.47Ϯ 0.02 for approximately cylindrical aggregation, as listed in Table I .
The late-time data are then also well described, and we observe that the extracted value of the geometry exponent is insensitive to the necessary modification of r. We reiterate, however, that r = 1 is required for the expected exponential decay of the monomer concentration at late times. The fact that this is in conflict with the empirical value of r used so far shows the limitation of the model. An obvious improvement would, of course, be to assume that the required deviations from r = 1 in Eqs. ͑4͒ and ͑6͒ tend to zero, i.e., that r → 1 at late times. In physical terms such a modification would be very well justified. For thaumatin and the TL protein this is because one would expect the density dependence of the activation process to die off as monomer collisions do when their density approaches zero. Likewise, the compensation for potential nucleation steps in the case of ␣-LA, by adjusting the value of r to around 2.5, should really only be applied during the early phases with r → 1 after nucleation.
The overall effect of this modification is expected to be small, however, because the model describes the data very well over almost the entire aggregation process, including the depletion of monomers and the subsequent plateau region, as seen, e.g., in Fig. 4 . Furthermore, the predicted geometry exponent is seen to be left unaffected. We therefore conclude that implementing r → 1 might be a rather cosmetic improvement. In doing so, the model would probably lose its mathematical simplicity which is one of its most appealing features.
Another limitation of the model in its present form is that there is no reference made to individual aggregates and their numbers. As a result, the model does not allow for the case where alternative growth pathways exist depending on the concentration of certain sizes of aggregates. For example, for large aggregate sizes, clumps of these big aggregates may begin to form rather than the simple addition of individual monomers to growing clusters. Therefore, further extensions of the model would need to account for a variable size distribution in order to rationalize and incorporate multiple aggregation pathways.
VI. CONCLUSIONS AND OUTLOOK
In this paper, we have proposed a model for aggregation involving a geometry exponent ␥ to model its various forms including the well-studied one-dimensional linear processes for ␥ = 0, two-dimensional or cylindrical processes for ␥ =1/ 2, and isotropic three-dimensional processes with ␥ =2/ 3. Moreover, this exponent can provide an indication of the geometry of the process and changes in geometry of the aggregates over time.
While simple in its form, the model is widely applicable to a number of amorphous aggregation processes, not necessarily limited to protein aggregation. To use this model on other systems, the experimentally obtained data simply need to be proportional to the volume of the aggregates and obey a scaling law; the method is, therefore, not limited to turbidimetry data.
Nevertheless, this model is very well suited to describe the turbidimetry data for the thaumatin protein presented herein as a first example. In particular, for thaumatin we observe that the first half of the aggregation process is very well described by an isotropic three-dimensional form corresponding to ␥ =2/ 3, while the second half displays more of a two-dimensional cylindrical behavior with ␥ Ϸ 1 / 2. Similar results are obtained for a TL protein and ␣-LA ͑whereby the rather limited scaling properties of the ␣-LA system lead to somewhat larger uncertainties-see Appendixes A and B͒.
A possible explanation for the geometry change at later times for the thaumatin protein may be that the hydrophobic interactions between aggregate and monomer are the primary modes of attraction ͓20͔ and, therefore, not all of the surface of an aggregate is available for a monomer to add. This is particularly the case for larger aggregates, where the hydrophobic regions will tend to point inward, exposing as little hydrophobicity as possible to the aqueous solution and hence reducing the number of sites available for monomers to add. Oblate deformations may result along with growth with reduced dimensionality in preferred directions. Whether it does or whether it leads to some other means to reduce the effective area relative to the volume is an open question which deserves further study.
An alternative explanation for the decrease in ␥ for later times could be that big aggregates might clump together to form huge aggregates. This would decrease the effective surface area available for monomer addition, consistent with the ␥ change. Furthermore, such a competing process would be more likely for later times when there are fewer monomers present and only big aggregates remain. Extensions of the model would need to account for such multiple growth pathways which depend on the size distribution of the aggregates at any time.
An analysis of the early-time behavior of the model shows that it is consistent with the experimental data and physical observations. On the other hand, we need to assume that r → 1 at late times to avoid the unphysical situation of a finite aggregation time. This is a minor limitation of the model which has little effect on the aggregation process as a whole. The model nevertheless reproduces the correct overall trends even at late times.
Future work will also include tests of the model in other systems. In addition, the findings could be reconciled with other data, such as time series of protein hydrodynamic radii as studied in ͓21͔. Finally, one could incorporate the capacity to include a number of nucleation steps prior to aggregation in the model along the lines of the linear aggregation model developed in Ref. ͓9͔ . This could then be used to devise a criterion for whether nucleation is important or not in any given amorphous aggregation process. 
Materials
Thaumatin ͑mixture of I and II͒ from Thaumatococcus daniellii was purchased from MP Biomedicals ͑Solon, OH, USA͒ and calcium depleted, type III, ␣-LA was purchased from Sigma Chemical Co. ͑St Louis, MO, USA͒, both being used without further purification. A thaumatinlike ͑TL͒ protein was isolated ͑Ͼ98% purity͒ from Semillon grape juice ͑Adelaide Hills, South Australia, 2005͒ by cation exchange and hydrophobic interaction chromatography ͓22͔. Dithiothreitol ͑DTT͒ was obtained from Sigma. All buffers and solutions were filtered ͑0.45 m͒ before use. cally at 280 nm with a Cary 5000 UV-visible spectrophotometer ͑Varian, Melbourne, VIC, Australia͒.
Determining protein concentrations
Concentrations of thaumatin ͑⑀
For the TL protein, the concentration of the final purified protein was determined by high-performance liquid chromatography ͓25͔.
Monitoring aggregation by turbidimetry
Stock solutions of thaumatin ͑5.0 mg/ml͒ in a model wine buffer solution ͑pH 3.2, 12% v / v ethanol/water, 1.25 g/l potassium hydrogen tartrate, and 1 g/l Na 2 SO 4 ͒ were prepared. Appropriate dilutions were made with the model wine buffer to give protein concentrations in 0.5 mg/ml increments from 2.0 to 4.0 mg/ml plus a control containing no protein ͑base-line͒. For the TL protein, the same model wine buffer was used except the pH was 3.5 and 100 mM potassium malate was included. The concentration range was 3.0-5.0 mg/ml in 0.5 mg/ml increments. Apo ␣-LA ͑10 mg/ml͒ in phosphate buffer ͑pH 7.2, 50 mM Na 3 PO 4 , 100 mM NaCl, and 2.5 mM ethylenediamine tetra-acetic acid͒ was used from 2.0-4.0 mg/ml in 0.5 mg/ml increments.
Incubation was at 60°C with 2 s of shaking after each 30 s cycle for thaumatin and the TL protein. The ␣-LA aggregation experiments were performed at 37°C ͑no shaking͒ and initiated by including DTT to a final concentration of 20 mM. The aggregation was monitored via turbidimetry at 340 nm using a Fluostar Optima microplate reader ͑BMG Labtechnologies, Melbourne, VIC, Australia͒. The data in each assay were averaged between duplicates and baseline subtracted, then normalized using the A ϱ value for 4.0 mg/ml ͑c 0 ref ͒ for each repetition such that the A ϱ turbidity values for 4.0 mg/ml were always 1.0 ͑justifiable because turbidity is an arbitrary scale͒. This procedure produced the aggregation profiles in the right column of Fig. 4 and those of Figs. 7 and 8, whereby the thaumatin and TL protein experiments were repeated three times and five times for ␣-LA due to the greater variability in the data.
APPENDIX B: TL PROTEIN AND ␣-LA RESULTS AND DISCUSSION
Inspection of Figs. 7 and 8 ͑left columns͒ shows that the individual data for the aggregation of the TL protein and ␣-lactalbumin ͑␣-LA͒, respectively, "scale" to an approximation. This allows us to use the scaling technique to analyze the data and fit the model to them in the same manner as described for thaumatin. It should be noted, however, that the scaling for ␣-LA is not as consistent as for thaumatin and the TL protein.
Once again, the double-logarithmic plots of the characteristic parameters produce straight lines for both the TL protein ͑Fig. 9, m = 0.039Ϯ 0.011͒ and ␣-LA ͑Fig. 10, m = 2.04Ϯ 0.39͒. The value of m for the TL protein is of the same order as thaumatin, but ␣-LA is two orders of magnitude greater than the other two. This is likely to be due to its dramatically different aggregation profile and that the conditions used to induce aggregation ͑i.e., reduction versus heating͒ lead to a much longer period of aggregation.
The fits by this amorphous aggregation model to the TL protein data produce strong correlations ͑Fig. 7͒ even though the data are slightly more noisy than for thaumatin. Replicates A1, B1, and C1 of Fig. 7 show that a ␥ value of 0.67 ͑the isotropic model͒ gives better fits for the early-time TL protein data, but the value which gives the best fit for mid to later times is ␥ Ϸ 0.40 ͑i.e., ␥ fit from Fig. 11͒ . Therefore, the same interpretation can be used as with thaumatin-there appears to be a change in the aggregate geometry from isotropically aggregating entities for early times, t Ͻ t 0 , to cylindrically aggregating entities for mid to later times, t Ͼ t 0 . Since the change in ␥ is more significant for the TL protein 98, 0.53, 0.98, 0.99, and 0.99, and values of 27.7, 56.7, 36.8, 25.2, and 96.7 min, corresponding on these plots to the t 0 values with A ϱ = 1.0. This gives mean values of m = 2.04Ϯ 0.39 and = 48.6Ϯ 13.2 min, where errors are quoted as SEs of the mean. than thaumatin, it suggests that these effects are more exaggerated in the TL case, perhaps leading to greater oblateness.
The greater approximation to scaling for the ␣-LA data makes it difficult to draw any firm conclusions about whether the fits are improved by changing the geometry exponent, ␥. Figure 8 ͑replicates A1-E1͒ shows the fits to the scaled data by the model and it is difficult to distinguish whether the fit is improved by ␥ = 0.67 ͑iso͒ or ␥ fit ͑from Fig. 12͒ . While the latter gives a lower overall error in the fit, we cannot conclude with greater confidence whether ␥ = 0.67 gives better fits at early times. Therefore, we cannot interpret whether a change in aggregate shape occurs for ␣-LA. Nevertheless, the same overall trend is observed, that is ␥ fit is near 0.5.
The less consistent scaling of ␣-LA could be due to the longer time period of aggregation exaggerating the effect of scaling with t 0 . It could also be due to the greater variation of the profiles between experiments. Finally, it may be that different mechanisms are involved for the concentration range examined and therefore scaling would not be expected to occur. In fact, higher concentrations do not scale nearly as well ͑data not shown͒, indicating that the latter may be the case.
While the fits by the model are reasonable, improvements could be made for ␣-LA, for example, by adding several nucleation steps to the model. This would be a reasonable approach since it is thought that ␣-LA aggregation occurs via a nucleation-dependent pathway. 
